Xuan Liu

8PUBLICATIONS
20CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Traditional Chinese medicine and treatmentsMolecular targetsCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 08, 2025
Astragaloside IV Binds with RhoA, Inhibits EndMT and Ameliorates Myocardial Fibrosis in Mice.

Qiongsen Wang, Ruiqin Zhang, Nan Li

|Jul 13, 2023
Corylifol A ameliorates muscle atrophy by inhibiting TAOK1/p38-MAPK/FoxO3 pathway in cancer cachexia.

Ruiqin Zhang, Qiang Shen, Yueping Wang

|Sep 23, 2022
Carnosol attenuated atrophy of C2C12 myotubes induced by tumour-derived exosomal miR-183-5p through inhibiting Smad3 pathway activation and keeping mitochondrial respiration.

Ji-Xia Kuang, Qiang Shen, Rui-Qin Zhang

|Sep 10, 2022
Atractylenolide I ameliorates cancer cachexia through inhibiting biogenesis of IL-6 and tumour-derived extracellular vesicles.

Meng Fan, Xiaofan Gu, Wanli Zhang

|Apr 05, 2022
GDF-15 in tumor-derived exosomes promotes muscle atrophy via Bcl-2/caspase-3 pathway.

Wanli Zhang, Weikuan Sun, Xiaofan Gu

|Jan 16, 2022
The critical role of STAT3 in biogenesis of tumor-derived exosomes with potency of inducing cancer cachexia in vitro and in vivo.

Meng Fan, Weikuan Sun, Xiaofan Gu

Pageof 2

Frequent Collaborators

6 joint publications

Xiongwen Zhang

3 joint publications

Wanli Zhang

3 joint publications

Qiang Shen

3 joint publications

Xiaofan Gu